Durham, NC, United States of America

Daryl Lynn McDougald

This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Wellcome Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daryl Lynn McDougald. Retrieved from https://idiyas.com/inventor/daryl-lynn-mcdougald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daryl Lynn McDougald: Innovator in Therapeutic Agents

Introduction

Daryl Lynn McDougald is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of therapeutic agents, holding a total of 2 patents. Her work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Among her latest patents is a family of compounds known as Formamide compounds, which are recognized for their therapeutic applications. These compounds possess a general structural formula that highlights their potential in medical science.

Career Highlights

Daryl is currently employed at Glaxo Wellcome Inc., where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking innovations.

Collaborations

Daryl has worked alongside notable colleagues, including Robert Carl Andrews and Marc W. Andersen. Their combined expertise fosters a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Daryl Lynn McDougald's work exemplifies the spirit of innovation in the field of therapeutic agents. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…